Orbit Discovery to attend 3rd Annual Targeted Radiopharmaceuticals Summit

July 10, 2024

Orbit Discovery CEO, Neil Butt, will be attending the 3rd Annual Targeted Radiopharmaceuticals Summit in San Diego, CA from July 30th to August 1st.Orbit has a growing presence in the targeted radiopharmceutical space thanks to its innovative peptide discovery platform.Please connect with Neil if you are interested in applying Orbit's platforms to your own company's targetting peptide discovery efforts.

Work With Us
As administrators Sue Staunton and Sandra Mundy manage the business, affairs and property of the Company and its agents and without personal liability.

Orbit Discovery Limited registered in England and Wales no.12850396 Registered office The White Building 1-4 Cumberland PlaceSouthampton SO15 2NP. VAT registration number 359593151’.

‍
Orbit Discovery work with Big Pharma and
Small Biotechs alike.

Find out how Orbit Discovery can help with your peptide discovery needs
Contact Us